Trade Mark Journal No.2026/001 2 January 2026
WO0000001892741 (1)
Office of origin: United States of America
Date of International Registration:16 November 2025
Date of designation in the UK:
16 November 2025

International priority date claimed: 14 November 2025
(United States of America)
(99496466)
- Class 1
- Excipients for use in the manufacture of pharmaceutical preparations.
SPI Pharma, Inc.
Representative: William C Wright Epstein Drangel LLP, 60 East 42nd Street, Suite 1250, New York NY 10165, UNITED STATES OF AMERICA